Medistim ASA announced the launch of the Pay Per Procedure functionality to latest MiraQTM platform in the US market. Medistim utilizes several business models to effectively reach different segments of the US market. In addition to traditional capital investments and purchase of consumables, hospitals can choose to enter leasing agreements or Pay Per Procedure. The PPP functionality has proven to be a popular option with previous generation of medical device. VeriQTM and VeriQCTM and will now also be available to MiraQ customers.